Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization.
Mark T Bokhart, Elias Rosen, Corbin Thompson, Craig Sykes, Angela D M Kashuba, David C Muddiman
Index: Anal. Bioanal. Chem 407(8) , 2073-84, (2015)
Full Text: HTML
Abstract
A quantitative mass spectrometry imaging (QMSI) technique using infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI) is demonstrated for the antiretroviral (ARV) drug emtricitabine in incubated human cervical tissue. Method development of the QMSI technique leads to a gain in sensitivity and removal of interferences for several ARV drugs. Analyte response was significantly improved by a detailed evaluation of several cationization agents. Increased sensitivity and removal of an isobaric interference was demonstrated with sodium chloride in the electrospray solvent. Voxel-to-voxel variability was improved for the MSI experiments by normalizing analyte abundance to a uniformly applied compound with similar characteristics to the drug of interest. Finally, emtricitabine was quantified in tissue with a calibration curve generated from the stable isotope-labeled analog of emtricitabine followed by cross-validation using liquid chromatography tandem mass spectrometry (LC-MS/MS). The quantitative IR-MALDESI analysis proved to be reproducible with an emtricitabine concentration of 17.2 ± 1.8 μg/gtissue. This amount corresponds to the detection of 7 fmol/voxel in the IR-MALDESI QMSI experiment. Adjacent tissue slices were analyzed using LC-MS/MS which resulted in an emtricitabine concentration of 28.4 ± 2.8 μg/gtissue.
Related Compounds
Related Articles:
2015-01-15
[J. Ethnopharmacol. 159 , 93-101, (2014)]
2014-11-01
[J. Am. Soc. Mass Spectrom. 25(11) , 1897-907, (2014)]
2014-12-01
[Biochim. Biophys. Acta 1842(12 Pt A) , 2345-56, (2014)]
2015-02-13
[J. Chromatogr. A. 1381 , 54-63, (2015)]
2014-12-30
[Proc. Natl. Acad. Sci. U. S. A. 111(52) , 18709-14, (2014)]